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doi:10.1016/j.ejvs.2010.09.007Abstract Objectives: Biophotonic imaging was compared to standard enumeration method
both for counting Staphylococcus aureus in biofilm and bacterial susceptibility tests of
different graft materials.
Design: Prospective, randomized, controlled animal study.
Material and methods: Five types of vascular grafts were placed subcutaneously in 35 mice
and challenged with bioluminescent S. aureus. The mice were divided into equal groups as
follows: group A (polyester), group B (polytetrafluoroethylene), group C and D (two types of
silver acetate-coated polyester) and group E (bovine pericardium). Controls were given only
the bacteria. The bioluminescence signal of S. aureus, able to predict number of viable
bacteria in biofilm without any manipulation, was measured at different time points. Five days
postinfection, regular cultures of adherent bacteria on grafts were obtained. Comparative
analyses between bioluminescence activity and culture enumeration were performed.
Results: The number of viable bacteria on silver-coated prostheses was the slightest, indi-
cating superior bacterial resistance. The density of bacteria on polytetrafluoroethylene and
polyester was comparable, with a non-significant advantage for polytetrafluoroethylene. More-
over, bioluminescence detected the number of viable S. aureus in biofilm more exactly
compared to enumeration of bacteria.
Conclusion: Bioluminescence imaging can be considered a useful tool to characterize suscep-
tibility of any graft material to bacterial biofilm prior to implantation.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.-wuerzburg.de (U. Lorenz).
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The increasing use of alloplastic bypass materials in modern
vascular surgery is associated with a variable but definite
risk of bacterial infection, which occurs in 1e4% of patients
with aortic grafts and in up to12% of patients with periph-
eral lower extremity bypass surgeries.1 Prosthetic vascular
graft infection (PVGI) causes substantial morbidity and
mortality, increased length-of-stay in hospital, and a high
amputation rate.1,2 Its treatment also imposes a consider-
able financial burden on any health-care system.
The prevention of PVGI is a great challenge in clinical
practice. Although the aetiology of PVGI in individual cases is
often unknown, intra-operative contaminationwith bacteria
is thought to be the major cause of early graft infection,
followed by wound infection and haematogenous bacterial
spread.3 Haematogenous and lymphogenous seeding may
occur early or late after prosthetic graft implantation.
Intracavitary graft infections (involving aorto-iliac, aorto-
femoral or iliofemoral grafts) tend to present late. The
interpretation of clinical PVGI data is sometimes hampered
by the small number and heterogeneity of patients, differ-
ences in the underlying microorganism, and the variable
clinical course of the infection. Staphylococcus aureus is the
leading cause of PVGI and the capacity to adhere and to form
multilayered communities, termed ‘biofilm’ on the surfaces
of implanted prostheses appears to be one of the major
causes of persistent infection following surgery.4 To better
understand and control infection on vascular prostheses,
preclinical model systems should be used to determine the
properties of different materials in resisting bacterial bio-
film.5 These systems should closely simulate the in situ
conditions for each graft, while at the same time providing
reproducible, accurate results.
In the past, the most common method to determine the
extent of PVGI required the sequential sacrificing of the study
animals to count the number of bacteria at a certain time
point. Such an invasive approach makes it difficult to follow
the kinetics of growth of bacteria within the biofilm.
Furthermore, enumerationbased oncolony-formingunit (cfu)
method has not been advised to quantify bacteria in biofilm.6
Recently, a new method of bioluminescence imaging was
developed for evaluating bacterial biofilm infection on
medical devices.7 This technique can be used for non-
invasive continuous monitoring of bacterial density and
growth on biomaterials.8 In the present study, we evaluated
the ability of this method to monitor bacterial biofilm on
vascular grafts in an experimental in vivo model in mice.
We compared the susceptibilities of silver-coated, poly-
tetrafluoroethylene, polyester and bovine pericardium
grafts to S. aureus biofilm. In addition, the goal of this
article was to determine the advantages of the biolumi-
nescence method in comparison to the bacterial enumer-
ation method.
Materials and Methods
Animals
All animal studies were approved by the Ethics Committee
of the University of Wuerzburg. Age- and gender-matchedNMRI (Naval Medical Research Institute) mice (Charles
River, Sulzfeld, Germany) were studied.
Prostheses material
The following five types of vascular prostheses material
were used: polyethylene terephthalate, a resin of the
polyester family (InterGard, Intervascular, La Ciotat
Cedex, France), polytetrafluoroethylene (ePTFE; Impra,
Bard, Tempe, AZ, USA), silver acetate-coated knitted
polyester (I) (InterGard Silver, InterVascular, La Ciotat
Cedex, France), silver acetate-knitted polyester (II) (Silver
Graft, Braun, Melsungen, Germany) and bovine pericardium
(VascuGuard, Synovis, Minnesota, USA).
Surgical model
All the implanted grafts were 1 cm2 in size. Mice of each
group were intra-peritoneally anesthetised with xylazin
(8 mg kg1 body weight) and ketamine (100 mg kg1 body
weight), the hair on the back was shaved and the skin was
cleansed with Octenisept solution (Schu¨lke & Mayr., Nor-
derstedt, Germany). One subcutaneous pocket was made
on each side of the median line in the lower back area
through a 1-cm-long incision. One square centimetre of
each sterile prosthesis material was implanted aseptically
into the pockets and the incision closed with sutures.
Sterile saline solution (0.1 ml) containing the S. aureus
Xen29 strain at a concentration of 1  108 cfu ml1 was
inoculated onto the graft surface using a syringe to create
a subcutaneous fluid-filled pocket. Control mice (n Z 7)
received only the bacteria without any graft material. The
animals were returned to individual cages and thoroughly
examined daily.
Bacterial strain
Bioluminescent S. aureus strain Xen29 was used for chal-
lenging. S. aureus Xen29 is a genetically engineered isolate
of the parental strain ATCC 12600 expressing a modified
Photorhabdus luminescence lux operon.7 The strain was
obtained commercially from Xenogen Corporation (now
part of Caliper Life Sciences, Hopkinton, MA, USA). The
ability of this strain to produce biofilm and in vivo virulence
has been shown.7,9
A single colony of the strain was used to inoculate
a 25-ml 2  YT broth culture overnight at 37 C. The culture
was washed in phosphate-buffered saline (PBS) and serially
diluted to obtain a concentration of 1  108 cfu ml1 cfus as
confirmed by quantitative culture analysis. The bacteria
were suspended in 0.1 ml of physiologic NaCl solution for
application.
Experimental protocol
Vascular graft materials were placed subcutaneously in 35
mice with polyester graft material in group A (n Z 7),
polytetrafluoroethylene graft material in group B (n Z 7),
two types of silver acetate-coated polyester graft materials
in groups C and D (nZ 7 each) and bovine pericardium graft
material in group E (n Z 7).
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After infection with bioluminescent S. aureus Xen29, the
mice were anaesthetised with inhaled isoflurane and imaged
according to a defined time schedule (15 min, 2 h and 1e5
days postinfection) using the Berthold NightOWL low-light
imaging system (Berthold, Bad Wildbad, Germany). Total
photon emissions from predefined regions of interest (ROIs)
with metabolically active S. aureus in each animal were
acquired for 1 min. The captured images were then quanti-
fied using the indiGo software package (Berthold, Bad
Wildbad, Germany).
Bioluminescent signals from the ROI were expressed in
a pseudo-colour image, with red representing the most
intense luminescence and blue representing the least. This
image was overlaid on a grey-scale reference image to
generate a two-dimensional picture of the distribution of
bioluminescent bacteria on the graft surface; the data are
presented as the cumulative photon counts (photons per
second (ps1)) collected within each individual ROI. The
image data were analysed and pictures were created using
Adobe Photoshop CS2.
Assessment of graft contamination
The grafts were aseptically harvested from mice 5 days
after infection, gently washed in sterile saline solution and
placed in tubes containing 10 ml of PBS solution. They were
then sonicated for 5 min to remove the adherent bacteria
from the grafts and homogenised in sterile PBS. Quantifi-
cation of viable bacteria was done by culturing serial 10-
fold dilutions (0.1 ml) of the bacterial suspension onto agar
plates. All plates were incubated at 37 C for 48 h and
evaluated for the presence of the S. aureus Xen29 strain.
The organisms were quantified by counting the number of
cfu per plate.Figure 1 Correlation between non-invasive bioluminescence ima
subcutaneously applied to the median line of the lower back area
emission is represented as a pseudocolour image. In vivo biolumin
enumerating bacteria in colony-forming units (cfu) were plotted
indicating a positive correlation between the two methods.Statistical methods
Bioluminescence intensity is reported as mean  S.D.
Bacterial counts are visualised as scatter dot plot with
mean line graphics. Statistical comparisons between the
two groups were made using the ManneWhitney-U test. The
GraphPad Prism program (GraphPad Software, Inc., La
Jolla, CA, USA) was used to analyse and graphically present
the data.
Results
Clinical course
None of the animals died or had clinical evidence of adverse
effects, such as local signs of perigraft inflammation,
anorexia, vomiting, diarrhoea or changes in behaviour.
Biophotonic imaging of infected prostheses
material
Real-time in vivo bioluminescence of subcutaneous
S. aureus Xen29 correlated to the total number of bacteria
(r2 Z 0.75), suggesting that bioimaging provides an accu-
rate evaluation of bacterial burden (Fig. 1). The biolumi-
nescent images of a representative animal selected from
each group and associated mean bioluminescent signals
(total flux in ps1) after contamination of implanted grafts
are shown in Fig. 2 (panels A and B). At 15 min after
bacterial infection, each graft group had a similar mean
bioluminescent signal at the site of contamination. The
bioluminescent signal intensity declined in the two groups
with silver-coated graft material (C and D) over the course
of 2 h. In the other groups (A, B and E), the mean biolu-
minescent signal remained steady from 15 min to 2 h, andging and bacterial burden. Bioluminescent S. aureus Xen29 was
of whole animals. The intensity of the transcutaneous photon
escence signal in photons per second (p/s) and plate count for
against each other. Regression analysis yielded r2 Z 0.75,
S. aureus Biofilm Graft Infection 71then declined by day 1. A progressive reduction in the
bioluminescent signal was observed in all graft groups after
24 h, dropping as low as approximately 5 105e1 106 ps1
in all but group E (bovine pericardium), which fell to
2.41 106 ps1. In control animals, the bioluminescent signal
showed a continued increase until 24 h post-contamination,
after which it declined to undetectable levels by the end of
the observation period.
The bioluminescent signals peaked again 2 days after
graft contamination in all groups except group E, where the
peak value was reached on day 3. Afterwards, the biolu-
minescent signals declined gradually to the lowest level in
the respective groups until the end of the observationFigure 2 Time series of photon detection from metabolically act
mice during a 5-day follow-up. (A) The dynamic of bioluminesce
contamination of vascular graft materials with 1  107 cfu S au
intensity of a representative mouse of each group with indicated
corresponds to the time points indicated in the graph of panel B. (B)
per second (p/s)) of mice were plotted as a function of time. ())
after contamination are displayed.period on day 5, but were undetectable in groups C and D
(silver-coated prostheses). Overall, the curve shapes in the
groups were closely similar on different kinetic levels. The
highest overall signal intensity was seen for animals in
group E with bovine pericardium graft material, followed in
descending order by groups A, C, B and D.
At the end of the observation period on day 5 of graft
infection, the mean total flux (ps1) reached 4.75  105 in
group A (polyester), 1.86  105 in group B (ePTFE) and
1.77  106 in group E (bovine pericardium). One of seven
animals (14%) had no detectable signal in group B and 2 of 7
(29%) in group A. All animals in group E had traceable
bioluminescence signals. In groups C (silver I) and D (silverive S. aureus within biofilms on different vascular prostheses in
nce levels was monitored 15 min, 2 h and on day 1e5 after
reus Xen29. Pseudocolor representation of bioluminescence
graft material (legend) is presented. The time of monitoring
Corresponding mean luminescence (SD) (total flux in photons
Significant differences between the indicated groups on day 5
72 U. Lorenz et al.II), the mean bioluminescent signal was zero, with only
a marginally detectable signal in two animals in group C.
Bacterial counting on contaminated prostheses
materials
The comparative analyses between bioluminescence and
the traditional colony-counting method after 5 days of graft
challenge with S. aureus Xen29 are summarised in Fig. 3
and Table 1.
No evidence of graft contamination was detected on any
explanted graft in group D (silver II). In group C (silver I), only
2 of 7 (29%) explanted grafts showed a low count of 10 and
30 cfu cm2. In accordance, the bioluminescence signal was
also positive but not quantifiable in these two animals. The
quantitative graft cultures of the other groups exhibited
variable bacterial growth. In group A (polyester), 5 of 7 (71%)
grafts showed bacterial growth, three of which had 1  103,
2  103 and 4  103 bacteriacm2. The other two grafts had
low counts of 10 and 30 cfu cm2. By contrast, all seven
animals in group A had a detectable bioluminescence signal.
In group B (PTFE), 5 of 7 (71%) grafts showed bacterial
growth. Only two had moderate counts of 3  103 and
1.5 104 cfu cm2. The other three grafts had low counts of
20 and 10 cfu cm2. In this group, only 1 of 7 animals had no
detectable bioluminescence signal. In group E, every graft
exhibited moderate bacterial growth with a mean (range)
count of 2 103 (6 102e9 103) cfu cm2. In this group, all
animals showed consistently detectable bioluminescence
signals.
Discussion
In 1993, the Ad Hoc Committee of the Joint Councils of the
Society for Vascular Surgery and International Society for
Cardiovascular Surgery, North American Chapter, proposedFigure 3 Recovery of S. aureus strain Xen29 following
subcutaneous challenge of vascular graft materials with 1  107
bacteria. The number of cfu was determined by differential
plating analysis. The number of cfu from the investigated graft
materials (polyester, polytetrafluoroethylene, silver I, silver II,
bovine pericardium) of animals were visualised as scatter dot
blot with the horizontal line denotes the mean value. Signifi-
cant differences between the groups are indicated.a comprehensive performance and procedure standard for
arterial prostheses.5 Besides other characteristics, the ideal
prosthetic material should be resistant to infection as are
human arteries. Although several attempts have been made
to improve resistance to bacterial contamination, no
currently available prosthetic graft completely fulfils this
criterion. The creation of a prosthetic vascular graft that is
able to eliminate thenatural ability of bacteria to adhere and
to develop biofilm requires considerable further scientific
investigation. In this context, reliable preclinical in vivo
model systems to test new concepts of altering surface
properties by physical, chemical andbiologicalmodifications
serve as preliminary steps for the improvement of the anti-
infectious characteristics of vascular grafts.
To date, the design of animal studies usually requires
removal of infected grafts at each sampling point to indi-
rectly estimate the pathogen burden by measuring the
bacterial count.10e12 This method needs large numbers of
animals and it does not permit direct monitoring of the
infection over time.13,14 Moreover, the enumeration of
bacteria is a great challenge, especially in graft-associated
biofilm infection.15 In particular, the manipulation of graft
materials by vortex or sonication to successively count
adherent bacteria presents disadvantages as they may not
detach all bacteria or may alter bacterial viability leading
to inaccurate counts.
A potential solution to these drawbacks is biophotonic
imaging, as first described by Contag et al.16 and later by
Burns et al.17 for monitoring Gram-negative bacterial
infections. Gram-positive bacteria including S. aureus
strains can also be made bioluminescent through the stable
integration of an optimised P. luminescence luxABCDE
cassette onto their chromosome as first described by
Francis et al.18
In the present study, we examined whether the in vivo
model of biophotonic imaging could be adapted to allow
continuous monitoring of bacterial biofilm colonisation for
a certain period after graft contamination.
The study design was chosen for several reasons. First,
direct inoculation of bacteria mimics contamination of
vascular grafts at the time of implantation, the foremost
reason for early graft infection.19 Although transient bac-
teraemia as a source of infection is well described in exper-
imental investigations,20 the clinical evidence remains
speculative. Second, staphylococci are the most important
pathogens in PVGI.21 Third, although the prosthetic material
was not implanted into the continuity of an arterial vessel,
the subcutaneous graft placement may reproduce an envi-
ronment similar to the clinical situation. Further, fourthly,
the direct correlation between S. aureus density on medical
devices and the measured bioluminescent signal intensity
has been shown.18,22
In our model, the kinetics of graft infection as a measure
of bioluminescence exhibited some specific features. In the
control group without prosthetic material implantation, for
example, no bacterial proliferation was found prior to 24 h
post-contamination. This suggests that the implantation of
any prosthetic material supports bacterial survival and
growth. In agreement, a foreign body reaction has been
identified as a predisposing factor to infection.23 The time
course of bioluminescence intensity in all prosthesis groups
showed a wavelike rhythmic pattern with an overall
Table 1 Bioluminescence and traditional bacterial determination method to count S. aureus Xen29 in biofilm after 5 days of
graft infection in a standardized mouse model.
Graft material Plate count method Bioluminescence signal
Detected Mean cfu (Range)/cm2 Detected Mean photons (Range)/sec
Polyester 5/7 3  101 (0e4.0  104) 7/7 4.7  105 (1.2  105e9.10  105)
PTFE 5/7 1  101 (0e1.5  104) 6/7 1.86  105 (0e9.68  105)
Silver I 2/7 0 (0e3.0  101) 2/7 0 (0e5.36  105)
Silver II 0/7 0 0/7 0
Bovine pericardium 7/7 2.0  103 (6  102e9103) 7/7 1.77  106 (7.3  105e1.8  106)
S. aureus Biofilm Graft Infection 73decreasing signal amplitude up to day 5 after infection.
This phenomenon mirrors probably the cyclic presence of
metabolically active bacteria in biofilm under the control of
the animal’s host defence mechanisms, which causes finally
a decrease in the bacterial density.24,25 In contrast to our
results, some previous studies have reported higher colo-
nisation rates over a certain time in similar mouse or rat
models with subcutaneously implanted vascular graft
materials.26,27 The apparent conflicting data might be
explained by using higher inoculum sizes and different
strains in these models. The number of bacteria needed to
produce a consistent growth and the biofilm formation
capacity varies from one strain to another. Another issue is
the choice of the experimental animal. Reproducible
infections in mice and rats are difficult to establish because
of their high natural resistance to staphylococci. For
example, it has been previously reported that various rat
strains behaved remarkably differently in prosthetic
contamination studies. Highly variable numbers of bacteria
adherent to the same foreign material were detected.28
Conclusively, it is difficult to compare directly the
number of biofilm-associated bacteria across different
studies.
Nevertheless, the variable extent of bioluminescence
signals among graft materials suggests truly different
abilities to resist bacterial growth on the surface.
Specifically, in the group with silver-coated prostheses,
the bioluminescence signal decreased rapidly after
contamination, whereas, with uncoated synthetic pros-
thetic materials, a decline was observed only after several
hours. Moreover, in the groups with silver-coated pros-
theses, almost no more signal activity could be detected
on the day of graft explantation. Hence, silvercoating
appears to confer superior in vivo resistance to staphylo-
coccal growth compared to the other uncoated materials.
Comparative analysis of the commonly used prosthetic
grafts polyester and ePTFE suggests the latter has better
resistance to staphylococcal adherence. Finally, the
bovine pericardium was significantly less resistant to
staphylococci compared to all other prostheses in this
model.
Of note, biophotonic imaging was able to detect more
often metabolically active bacteria within biofilm than
culture enumeration at the end of the study period. In
polyester, the study strain was identified in all cases by
biophotonic imaging, while the same bacterium was found
by enumeration only in five of seven cases. Similarly, one
more infected ePTFE graft was identified by biophotonic
imaging. The possibility to find more often low numbers ofviable bacteria on graft material by biophotonic imaging
may have great importance for interpreting bacterial
resistance of prostheses. The differential adherence of
bacteria to a prosthetic vascular graft determines its rela-
tive infectivity. In other words, the higher the load of vital
bacteria on the graft surface at any time, the greater is the
risk for late prosthetic vascular graft infection.29,30 The
presented findings on the individual prosthetic materials
accord with clinical or preclinical observations. The supe-
rior resistance to infection of silver-coated prostheses has
been reported in clinical studies.31,32 Furthermore, bacte-
rial strains have been shown to have greater affinity to
polyester than to PTFE,33,34 although the literature is
somewhat inconsistent.35 Some authors have advised
extracellular matrix biomaterials in the management of
graft infection.29,30 One such graft material with excellent
healing properties during implantation is bovine pericar-
dium, whose use as a replacement for other infected
prosthetic grafts has been discussed.36 This is in contrast
with our presented finding that bovine pericardium has low
resistance to infection. Previously published observations
are in line with our data.37
There are some limitations to our study. The used
experimental model is not directly comparable with the
implantation of grafts in human vessels and, therefore,
conservative interpretations of the presented results seem
advisable. Furthermore, we studied exclusively the early,
extracavitary graft contamination and only a single strain of
S. aureus was included. Long-term studies are required for
confirmation of the data.
In the present study, we show that biophotonic imaging
can quantify not only differences in resistance to infection
of various graft materials, but also that bacterial growth
can be monitored longitudinally, in real-time and non-
invasively in live animals. Bioluminescence allows more
sensitive detection of bacteria within biofilm on graft
surfaces. The experimental model presented here may be
ideally suited as an adjunct to other studies for pre-implant
evaluation of graft resistance to bacterial biofilm.
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